<DOC>
	<DOCNO>NCT02298218</DOCNO>
	<brief_summary>In clinical study , meloxicam use patient old 2 year underwent Kasai portoenterostomy treat biliary atresia . Before medication , liver stiffness score check use hepatic Fibroscan . Liver stiffness score compare medication meloxicam , roll COX-2 inhibitor ( meloxicam ) patient biliary atresia release hepatic fibrosis . Also , side effect drug check . The intervention drug , meloxicam safe medicine use treat pain inflammation cause osteoarthritis rheumatoid arthritis adult child least 2 year old . It may also use purpose list medication guide . It take daily dose 0.125 mg/kg/day ( high-dose group ) 0.06 mg/kg/day ( low-dose group ) . After 6 month medication , maintenance decide comparison liver stiffness score intervention .</brief_summary>
	<brief_title>Clinical Study About Role COX-2 Inhibitor Liver Cirrhosis With Biliary Atresia</brief_title>
	<detailed_description />
	<mesh_term>Biliary Atresia</mesh_term>
	<mesh_term>Meloxicam</mesh_term>
	<criteria>1 . Patients undergone Kasai portoenterostomy BA , postoperatively manage outpatient clinic 2 . Patients make informed consent clinical study COX2 inhibitor 3 . Patients follow liver fibroscan study 4 . Patients 2 year old less equal 17 year 1 . Patients impossible join clinical study underlie disease ( renal disease , liver disease , diabetes mellitus , GI disease , include bleeding , perforation , ulceration , etc . ) biliary atresia , ii ) H. pylori infection , iii ) asthma , iv ) nasal polyp , v ) hypertension , vi ) hematologic disease , vii ) coagulopathy , viii ) cardiac disease , ix ) vascular disease 2 . Patients get drug ( COX2 inhibitor ) 3 . Patients check liver fibroscan 4 . Patients impossible join clinical study complication Kasai portoenterostomy 5 . Patients make informed consent clinical study COX2 inhibitor 6 . Patients take drug allergy , skin disease asthma attack drug ( COX2 inhibitor ) 7 . Patients decide withdraw severe drug adverse event</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>